• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.22% Nasdaq Up2.00%

    Medtronic plc (MDT)

    -NYSE
    80.94 Up 0.64(0.80%) May 24, 4:02PM EDT
    ProfileGet Profile for:
    Medtronic plc
    20 On Hatch
    Lower Hatch Street
    Dublin, 2
    Ireland - Map
    Phone: 353 1 438 1700
    Website: http://www.medtronic.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Appliances & Equipment
    Full Time Employees:85,000

    Business Summary 

    Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators, implantable cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, and peripheral vascular intervention products. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery, such as ventilators, capnography, and other airway products; sensors; monitors; compression and dialysis products; enteral feeding; wound care; and medical surgical products comprising operating room supply products, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, and throat; systems that incorporate advanced energy surgical instruments; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps; continuous glucose monitoring systems; insulin pump consumables; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Medtronic plc

    Corporate Governance 
    Medtronic plc’s ISS Governance QuickScore as of May 1, 2016 is 4. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 5; Compensation: 3.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Omar S. Ishrak , 60
    Chairman and Chief Exec. Officer
    32.69M0.00
    Mr. Gary L. Ellis , 60
    Chief Financial Officer and Exec. VP
    11.20M1.16M
    Mr. Michael J. Coyle , 53
    Exec. VP and Group Pres of Cardiac & Vascular Group
    8.13M0.00
    Mr. Bryan C. Hanson , 49
    Exec. VP and Group Pres of Minimally Invasive Therapies Group
    4.75M0.00
    Dr. Richard E. Kuntz M.D., MSc., 59
    Chief Scientific, Clinical & Regulatory Officer and Sr. VP
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders